CIK 0001638097 · Non-accelerated filer<br>Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-2-532-7151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- D Other Notice of Sales of Unregistered Securities
- 4 Open-market buy Director bought 23,952 shares at $0.71 ($17,006)
- 4 Open-market buy Chief Executive Officer bought 23,952 shares at $0.71 ($17,006)
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Open-market buy Director bought 18,000 shares at $0.62 ($11,216)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.59 ($11,784)
- 4 Open-market buy Director bought 40,000 shares at $0.60 ($24,000)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- PRER14A Other PRER14A
- 8-K Event Delisting notice
- 25-NSE/A Other 25-NSE/A
Page 9 of 21 · 420 filings